Trial
NCT04571645
Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jazz Pharmaceuticals
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Dociparstat
Why stopped
Study enrollment was terminated on 16 May 2022 due to slow recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-15